vs

Side-by-side financial comparison of ARGENX SE (ARGX) and Venture Global, Inc. (VG). Click either name above to swap in a different company.

Venture Global, Inc. is the larger business by last-quarter revenue ($4.4B vs $2.5B, roughly 1.8× ARGENX SE). ARGENX SE runs the higher net margin — 35.5% vs 26.8%, a 8.7% gap on every dollar of revenue. On growth, Venture Global, Inc. posted the faster year-over-year revenue change (191.7% vs 83.2%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $-1.5B).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

S&P Global Inc. is an American publicly traded corporation headquartered in Manhattan, New York. Its primary areas of business are financial information, analytics, and energy and commodities intelligence. It is the parent company of S&P Global Ratings, S&P Global Energy, S&P Global Market Intelligence, S&P Global Mobility, and the Indian credit rating agency CRISIL. It is also the majority owner of the S&P Dow Jones Indices joint venture. "S&P" is a shortening of "Standard and Poor's".

ARGX vs VG — Head-to-Head

Bigger by revenue
VG
VG
1.8× larger
VG
$4.4B
$2.5B
ARGX
Growing faster (revenue YoY)
VG
VG
+108.5% gap
VG
191.7%
83.2%
ARGX
Higher net margin
ARGX
ARGX
8.7% more per $
ARGX
35.5%
26.8%
VG
More free cash flow
ARGX
ARGX
$1.8B more FCF
ARGX
$322.4M
$-1.5B
VG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARGX
ARGX
VG
VG
Revenue
$2.5B
$4.4B
Net Profit
$877.2M
$1.2B
Gross Margin
89.5%
Operating Margin
28.9%
38.7%
Net Margin
35.5%
26.8%
Revenue YoY
83.2%
191.7%
Net Profit YoY
1.3%
20.3%
EPS (diluted)
$13.25
$0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARGX
ARGX
VG
VG
Q4 25
$2.5B
$4.4B
Q3 25
$3.3B
Q2 25
$1.8B
$3.1B
Q1 25
$2.9B
Q4 24
$1.4B
$1.5B
Q3 24
$926.0M
Q2 24
$901.9M
$1.1B
Q1 24
$1.4B
Net Profit
ARGX
ARGX
VG
VG
Q4 25
$877.2M
$1.2B
Q3 25
$550.0M
Q2 25
$414.8M
$475.0M
Q1 25
$517.0M
Q4 24
$865.6M
$990.0M
Q3 24
$-294.0M
Q2 24
$-32.5M
$352.0M
Q1 24
$698.0M
Gross Margin
ARGX
ARGX
VG
VG
Q4 25
89.5%
Q3 25
Q2 25
89.2%
Q1 25
Q4 24
90.2%
Q3 24
Q2 24
89.4%
Q1 24
Operating Margin
ARGX
ARGX
VG
VG
Q4 25
28.9%
38.7%
Q3 25
39.7%
Q2 25
19.2%
33.5%
Q1 25
37.3%
Q4 24
8.7%
39.0%
Q3 24
20.4%
Q2 24
-15.4%
32.8%
Q1 24
43.6%
Net Margin
ARGX
ARGX
VG
VG
Q4 25
35.5%
26.8%
Q3 25
16.5%
Q2 25
23.4%
15.3%
Q1 25
17.9%
Q4 24
64.1%
65.0%
Q3 24
-31.7%
Q2 24
-3.6%
31.8%
Q1 24
49.4%
EPS (diluted)
ARGX
ARGX
VG
VG
Q4 25
$13.25
$0.41
Q3 25
$0.16
Q2 25
$6.32
$0.14
Q1 25
$0.15
Q4 24
$13.33
$0.35
Q3 24
$-0.15
Q2 24
$-0.55
$0.12
Q1 24
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARGX
ARGX
VG
VG
Cash + ST InvestmentsLiquidity on hand
$3.5B
$2.4B
Total DebtLower is stronger
$34.2B
Stockholders' EquityBook value
$7.3B
$6.7B
Total Assets
$8.7B
$53.4B
Debt / EquityLower = less leverage
5.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARGX
ARGX
VG
VG
Q4 25
$3.5B
$2.4B
Q3 25
$1.9B
Q2 25
$2.1B
$2.2B
Q1 25
$3.6B
Q4 24
$1.5B
$3.6B
Q3 24
Q2 24
$1.4B
Q1 24
Total Debt
ARGX
ARGX
VG
VG
Q4 25
$34.2B
Q3 25
$32.6B
Q2 25
$30.0B
Q1 25
$29.3B
Q4 24
$29.3B
Q3 24
Q2 24
$11.0M
Q1 24
Stockholders' Equity
ARGX
ARGX
VG
VG
Q4 25
$7.3B
$6.7B
Q3 25
$5.7B
Q2 25
$6.1B
$5.3B
Q1 25
$4.9B
Q4 24
$5.5B
$2.9B
Q3 24
Q2 24
$4.3B
Q1 24
Total Assets
ARGX
ARGX
VG
VG
Q4 25
$8.7B
$53.4B
Q3 25
$50.1B
Q2 25
$7.2B
$46.5B
Q1 25
$45.1B
Q4 24
$6.2B
$43.5B
Q3 24
Q2 24
$4.8B
Q1 24
Debt / Equity
ARGX
ARGX
VG
VG
Q4 25
5.07×
Q3 25
5.73×
Q2 25
5.69×
Q1 25
6.01×
Q4 24
10.11×
Q3 24
Q2 24
0.00×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARGX
ARGX
VG
VG
Operating Cash FlowLast quarter
$323.3M
$2.1B
Free Cash FlowOCF − Capex
$322.4M
$-1.5B
FCF MarginFCF / Revenue
13.0%
-34.1%
Capex IntensityCapex / Revenue
0.0%
81.6%
Cash ConversionOCF / Net Profit
0.37×
1.77×
TTM Free Cash FlowTrailing 4 quarters
$594.5M
$-6.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARGX
ARGX
VG
VG
Q4 25
$323.3M
$2.1B
Q3 25
$1.9B
Q2 25
$361.8M
$1.5B
Q1 25
$1.1B
Q4 24
$41.9M
Q3 24
Q2 24
$-124.7M
Q1 24
$638.0M
Free Cash Flow
ARGX
ARGX
VG
VG
Q4 25
$322.4M
$-1.5B
Q3 25
$-1.4B
Q2 25
$356.6M
$-1.5B
Q1 25
$-2.4B
Q4 24
$40.9M
Q3 24
Q2 24
$-125.5M
Q1 24
$-2.4B
FCF Margin
ARGX
ARGX
VG
VG
Q4 25
13.0%
-34.1%
Q3 25
-42.4%
Q2 25
20.1%
-49.1%
Q1 25
-81.3%
Q4 24
3.0%
Q3 24
Q2 24
-13.9%
Q1 24
-167.3%
Capex Intensity
ARGX
ARGX
VG
VG
Q4 25
0.0%
81.6%
Q3 25
98.9%
Q2 25
0.3%
96.1%
Q1 25
119.8%
Q4 24
0.1%
Q3 24
Q2 24
0.1%
Q1 24
212.4%
Cash Conversion
ARGX
ARGX
VG
VG
Q4 25
0.37×
1.77×
Q3 25
3.42×
Q2 25
0.87×
3.07×
Q1 25
2.15×
Q4 24
0.05×
Q3 24
Q2 24
Q1 24
0.91×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARGX
ARGX

Segment breakdown not available.

VG
VG

Plaquemines Project Segment$3.4B76%
Calcasieu Project Segment$841.0M19%
Other$208.0M5%

Related Comparisons